Related Experiment Video
Updated: Feb 12, 2026

Author Spotlight: A Battery of Highly Reproducible Behavioral Tests to Validate an Angelman Syndrome Murine Model
Published on: October 20, 2023
Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT
Thomas G Diness1, Yung-Hsin Yeh, Xiao Yan Qi
1Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, 5000 Belanger Street East, Montreal, Quebec, Canada H1T 1C8.
Aims:
Impaired repolarization in cardiac myocytes can lead to long QT syndrome (LQTS), with delayed repolarization and increased susceptibility to Torsades de Pointes (TdP) arrhythmias. Current pharmacological treatment of LQTS is often inadequate. This study sought to evaluate the antiarrhythmic effect of a novel compound (NS1643) that activates the rapid delayed-rectifier K+ current, I(Kr), in two rabbit models of acquired LQTS.
Methods And Results:
We used two clinically relevant in vivo rabbit models of TdP in which we infused NS1643 or vehicle: (i) three-week atrioventricular block with ventricular bradypacing; (ii) dofetilide-induced I(Kr) inhibition in methoxamine-sensitized rabbits. In addition, we studied effects on ionic currents in cardiomyocytes with I(Kr) suppressed by bradycardia remodelling or dofetilide exposure. Bradypaced rabbits developed QT interval prolongation, spontaneous ventricular ectopy, and TdP. Infusion of NS1643 completely suppressed arrhythmic activity and shortened the QT interval; vehicle had no effect. NS1643 also suppressed ventricular tachyarrhythmias caused by infusion of dofetilide to methoxamine-sensitized rabbits, and reversed dofetilide-induced QT prolongation. NS1643 increased I(Kr) in cardiomyocytes isolated from normal and bradycardia-remodelled rabbits by approximately 75% and 50%, respectively (P < 0.001 for each). Similarly, NS1643 restored I(Kr) suppressed by 5 nmol/L dofetilide (tail current 0.28 +/- 0.03 pA/pF pre-dofetilide, 0.20 +/- 0.01 pA/pF in the presence of dofetilide, 0.27 +/- 0.02 pA/pF after adding NS1643 to dofetilide-containing solution, P < 0.01).
Conclusion:
Pharmacological activation of I(Kr) reverses acquired LQTS and TdP caused by bradycardic remodelling and I(Kr)-blocking drugs. I(Kr)-activating drug therapy could be a potentially interesting treatment approach for LQTS.
Insights
A novel compound, NS1643, effectively treats long QT syndrome (LQTS) and Torsades de Pointes (TdP) arrhythmias by activating the rapid delayed-rectifier K+ current (I(Kr)). This study demonstrates NS1643
Area of Science:
- Cardiovascular Pharmacology
- Cardiac Electrophysiology
- Molecular Cardiology
Background:
- Impaired cardiac repolarization causes long QT syndrome (LQTS), increasing Torsades de Pointes (TdP) risk.
- Current LQTS treatments are often insufficient.
- The rapid delayed-rectifier K+ current (I(Kr)) is crucial for cardiac repolarization.
Purpose of the Study:
- To assess the antiarrhythmic efficacy of NS1643, a novel I(Kr)-activating compound.
- To evaluate NS1643 in rabbit models of acquired LQTS and TdP.
Main Methods:
- Two rabbit models of acquired LQTS and TdP were used: bradycardia-induced atrioventricular block and dofetilide-induced I(Kr) inhibition.
- NS1643 or vehicle was administered intravenously.
- Effects on ionic currents in isolated cardiomyocytes were analyzed.
Main Results:
- NS1643 completely abolished TdP and shortened the QT interval in bradycardic rabbits.
- NS1643 reversed dofetilide-induced QT prolongation and suppressed ventricular tachyarrhythmias.
- NS1643 significantly increased I(Kr) in cardiomyocytes, restoring current suppressed by bradycardia or dofetilide.
Conclusions:
- Pharmacological activation of I(Kr) effectively reverses acquired LQTS and TdP.
- NS1643 demonstrates potential as a therapeutic agent for LQTS.
- I(Kr)-activating drug therapy represents a promising treatment strategy for LQTS.
More Related Videos
06:48Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
10:31An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
Published on: April 20, 2018
Related Concept Videos
Bridge rectifier
Operationally, the bridge rectifier allows current flow through two of its diodes during each...
Half wave rectifier
Full wave rectifier
Properties of Enantiomers and Optical Activity
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Electrical Current